Improvement of European translational cancer research. Collaboration between comprehensive cancer centers.
Even though the increasing incidence of cancer is mainly a consequence of a population with a longer life span, part of this augmentation is related to the increasing prevalence of patients living with a chronic cancer disease. To fight the problem, improved preventive strategies are mandatory in combination with an innovative health care provision that is driven by research. To overcome the weakness of translational research the OECI is proposing a practical approach as part of a strategy foreseen by the EUROCAN+PLUS feasibility study, which was launched by the EC in order to identify mechanisms for the coordination of cancer research in Europe.
Cancer Center Karolinska, Karolinska University Hospital, Sweden. ulrik.ringborg@karolinska.se
Ulrik
U
Ringborg
Dominique
D
de Valeriola
Wim
W
van Harten
Antonio Llombart
AL
Bosch
Claudio
C
Lombardo
Kenneth
K
Nilsson
Thierry
T
Philip
Marco A
MA
Pierotti
Peter
P
Riegman
Mahasti
M
Saghatchian
Guy
G
Storme
Thomas
T
Tursz
Dirk
D
Verellen
D035843:Biomedical Research; D002173:Cancer Care Facilities / Q000639:trends; D002908:Chronic Disease; D003299:Cooperative Behavior; D005062:European Union; D006801:Humans; D009369:Neoplasms / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D009939:Organizations, Nonprofit; D015995:Prevalence